Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Jan;35(1):311–312. doi: 10.1128/jcm.35.1.311-312.1997

Indeterminate results of the second-generation hepatitis C virus (HCV) recombinant immunoblot assay: significance of high-level c22-3 reactivity and influence of HCV genotypes.

N N Zein 1, J J Germer 1, N K Wendt 1, C M Schimek 1, J N Thorvilson 1, P S Mitchell 1, D H Persing 1
PMCID: PMC229567  PMID: 8968936

Abstract

A second-generation recombinant immunoblot assay (RIBA 2.0) is used in the United States to confirm infection with hepatitis C virus (HCV) in samples that are anti-HCV (enzyme immunoassay) positive. In some cases, indeterminate results of RIBA 2.0, which are defined as reactivity to a single antigen species or reactivity limited to two proteins derived from the same coding region of the HCV genome, are encountered. This study was performed to establish the significance of indeterminate RIBA 2.0 results in relation to HCV RNA detection, high positivity for the c22-3 band, and the HCV genotype as determined by direct DNA sequencing. Ninety-six samples with indeterminate RIBA 2.0 results were studied. HCV RNA was detected in 21 of 34 (62%) samples with high reactivity to c22-3 and in 8 of 62 (13%) samples with low reactivity to c22-3. The HCV genotype distribution in samples that were RIBA 2.0 indeterminate and HCV RNA positive was significantly different from that in samples of a control group with positive results for both the RIBA 2.0 and HCV PCR. These results suggest that highly positive c22-3 samples are likely to be associated with HCV viremia and that infection with less common HCV genotypes is more commonly associated with indeterminate RIBA 2.0 results.

Full Text

The Full Text of this article is available as a PDF (138.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allain J. P., Rankin A., Kuhns M. C., McNamara A. Clinical importance of HCV confirmatory testing in blood donors. Lancet. 1992 May 9;339(8802):1171–1172. doi: 10.1016/0140-6736(92)90772-u. [DOI] [PubMed] [Google Scholar]
  2. Chen P. J., Lin M. H., Tai K. F., Liu P. C., Lin C. J., Chen D. S. The Taiwanese hepatitis C virus genome: sequence determination and mapping the 5' termini of viral genomic and antigenomic RNA. Virology. 1992 May;188(1):102–113. doi: 10.1016/0042-6822(92)90739-c. [DOI] [PubMed] [Google Scholar]
  3. Delisse A. M., Descurieux M., Rutgers T., D'Hondt E., De Wilde M., Arima T., Barrera-Sala J. M., Ercilla M. G., Ruelle J. L., Cabezon T. Sequence analysis of the putative structural genes of hepatitis C virus from Japanese and European origin. J Hepatol. 1991;13 (Suppl 4):S20–S23. doi: 10.1016/0168-8278(91)90017-6. [DOI] [PubMed] [Google Scholar]
  4. Enomoto N., Takada A., Nakao T., Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun. 1990 Aug 16;170(3):1021–1025. doi: 10.1016/0006-291x(90)90494-8. [DOI] [PubMed] [Google Scholar]
  5. Follett E. A., Dow B. C., McOmish F., Yap P. L., Hughes W., Mitchell R., Simmonds P. HCV confirmatory testing of blood donors. Lancet. 1991 Oct 19;338(8773):1024–1024. doi: 10.1016/0140-6736(91)91891-w. [DOI] [PubMed] [Google Scholar]
  6. Gretch D., Lee W., Corey L. Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory. J Clin Microbiol. 1992 Aug;30(8):2145–2149. doi: 10.1128/jcm.30.8.2145-2149.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Halfon P., Rousseau S., Tamalet C., Antoni M., Gerolami V., Levy M., Bourliere M., Planells R., Cartouzou G. Indeterminate second-generation hepatitis C recombinant immunoblot test: detection of hepatitis C virus infection by polymerase chain reaction. J Infect Dis. 1992 Aug;166(2):449–449. doi: 10.1093/infdis/166.2.449. [DOI] [PubMed] [Google Scholar]
  8. Houghton M., Weiner A., Han J., Kuo G., Choo Q. L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology. 1991 Aug;14(2):381–388. [PubMed] [Google Scholar]
  9. Li J. S., Tong S. P., Vitvitski L., Lepot D., Trépo C. Evidence of two major genotypes of hepatitis C virus in France and close relatedness of the predominant one with the prototype virus. J Hepatol. 1991;13 (Suppl 4):S33–S37. doi: 10.1016/0168-8278(91)90019-8. [DOI] [PubMed] [Google Scholar]
  10. Li J. S., Tong S. P., Vitvitski L., Lepot D., Trépo C. Two French genotypes of hepatitis C virus: homology of the predominant genotype with the prototype American strain. Gene. 1991 Sep 15;105(2):167–172. doi: 10.1016/0378-1119(91)90147-4. [DOI] [PubMed] [Google Scholar]
  11. Okamoto H., Kurai K., Okada S., Yamamoto K., Lizuka H., Tanaka T., Fukuda S., Tsuda F., Mishiro S. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology. 1992 May;188(1):331–341. doi: 10.1016/0042-6822(92)90762-e. [DOI] [PubMed] [Google Scholar]
  12. Pawlotsky J. M., Fleury A., Choukroun V., Deforges L., Roudot-Thoraval F., Aumont P., Duval J., Dhumeaux D. Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA. J Clin Microbiol. 1994 May;32(5):1357–1359. doi: 10.1128/jcm.32.5.1357-1359.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Simmonds P., Alberti A., Alter H. J., Bonino F., Bradley D. W., Brechot C., Brouwer J. T., Chan S. W., Chayama K., Chen D. S. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 1994 May;19(5):1321–1324. [PubMed] [Google Scholar]
  14. Van der Poel C. L., Cuypers H. T., Reesink H. W., Weiner A. J., Quan S., Di Nello R., Van Boven J. J., Winkel I., Mulder-Folkerts D., Exel-Oehlers P. J. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet. 1991 Feb 9;337(8737):317–319. doi: 10.1016/0140-6736(91)90942-i. [DOI] [PubMed] [Google Scholar]
  15. Zein N. N., McGreger C. G., Wendt N. K., Schwab K., Mitchell P. S., Persing D. H., Rakela J. Prevalence and outcome of hepatitis C infection among heart transplant recipients. J Heart Lung Transplant. 1995 Sep-Oct;14(5):865–869. [PubMed] [Google Scholar]
  16. Zein N. N., Rakela J., Persing D. H. Genotype-dependent serologic reactivities in patients infected with hepatitis C virus in the United States. Mayo Clin Proc. 1995 May;70(5):449–452. doi: 10.4065/70.5.449. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES